The Technical Analyst
Core Laboratories NV [CLB]
Exchange: NYSE Sector: Energy Industry: Oil & Gas Equipment & Services
Core Laboratories NV Price, Forecast, Insider, Ratings, Fundamentals & Signals
2.40% $16.84
America/New_York / 9 mai 2024 @ 11:58
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 789.56 mill |
| EPS: | 0.510 |
| P/E: | 33.01 |
| Earnings Date: | Jul 24, 2024 |
| SharesOutstanding: | 46.90 mill |
| Avg Daily Volume: | 0.397 mill |
| RATING 2024-05-08 |
|---|
| A- |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Buy | |
| P/E: | Strong Buy | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 1.72x |
| Company: PE 33.01 | sector: PE 19.21 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0.21x |
| Company: PE 33.01 | industry: PE 154.62 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.204 (-98.79%) $-16.63 |
| Date: 2024-05-09 |
| Expected Trading Range (DAY) |
|---|
|
$ 16.31 - 17.40 ( +/- 3.22%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-12-31 | Hill Christopher Scott | Sell | 14 195 | Common Stock |
| 2023-12-31 | Bruno Lawrence | Sell | 39 373 | Common Stock |
| 2023-12-31 | Hill Christopher Scott | Buy | 36 072 | Common Stock |
| 2023-12-31 | Hill Christopher Scott | Sell | 13 870 | Common Stock |
| 2023-12-31 | Hill Christopher Scott | Sell | 36 072 | Performance Shares |
| INSIDER POWER |
|---|
| 0.68 |
| Last 100 transactions |
| Buy: 936 848 | Sell: 632 052 |
Forecast:
13:37 - $17.07
Live Trading Signals (every 1 min)
Forecast
1: 12:07 - $16.82
Forecast 2: 12:57 - $16.94
Forecast 3: 13:37 - $17.07
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $16.84 (2.40% ) |
| Volume | 0.0618 mill |
| Avg. Vol. | 0.397 mill |
| % of Avg. Vol | 15.55 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CLB
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CLB
Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock, reservoir fluid, and gas samples to enhance production and improve recovery of oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, and production. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. In addition, the company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. It operates approximately in 50 countries. The company was founded in 1936 and is based in Amstelveen, the Netherlands.
Latest Press Releases
2024-04-24 17:15:00 - Press Release
Core Lab Reports First Quarter 2024 Results
First quarter revenue of $129.6 million, up modestly sequentially and year-over-year first quarter operating income of $8.6 million; ex-items, $14.9 million, flat sequentially, up 3% year-over-year first quarter operating margins, ex-items, of 12% first quarter gaap eps of $0.07; ex-items, $0.19, flat sequentially and year-over-year first quarter free cash flow of $2.5 million company announces q2 2024 quarterly dividend houston , april 24, 2024 /prnewswire/ -- core laboratories inc. (nyse: "clb") ("core", "core lab", or the "company") reported first quarter 2024 revenue of $129,600,000. core's operating income was $8,600,000, with diluted earnings per share ("eps") of $0.07, all in accordance with u...
2024-01-31 17:21:00 - Press Release
Core Lab Reports Fourth Quarter And Full Year 2023 Results
Fourth quarter revenue of $128.2 million, up 2% sequentially fourth quarter operating income of $14.6 million; ex-items, $15.0 million, down 6% sequentially fourth quarter operating margins, ex-items, of 12% fourth quarter gaap eps of $0.14; ex-items, $0.19, down 14% sequentially fourth quarter free cash flow of $16.7 million fourth quarter debt reduced by $15.0 million or over 8% company announces q1 2024 quarterly dividend full year revenue of $510.0 million, up 4% full year operating income of $54.6 million; ex-items, $61.2 million, up 36% full year gaap eps of $0.86; ex-items, eps of $0.80, up 40% houston , jan. 31, 2024 /prnewswire/ -- core laboratories inc. (nyse: "clb") ("core", "core lab", or the "company") reported fourth quarter 2023 revenue of $128,200,000...
2024-01-02 16:00:00 - Press Release
Core Laboratories' Fourth Quarter 2023 Webcast At 7:30 A.m. Cst / 8:30 A.m.
Houston , jan. 2, 2024 /prnewswire/ -- core laboratories (nyse: "clb") will broadcast its fourth quarter 2023 conference call over the internet at 7:30 a.m. cst / 8:30 a.m.
2023-11-01 17:15:00 - Press Release
Core Lab Reports Third Quarter 2023 Results
Revenue of $125.3 million; down 2% sequentially; flat year-over-year operating income of $14.7 million; ex-items, $16.0 million, up over 2% sequentially; up 20% year-over-year operating margins, ex-items, of 13% gaap eps of $0.19; ex-items, $0.22, up 5% sequentially; up 24% year-over-year reservoir description operating margins, ex-items, of 17%; incremental margins exceeding 100% sequentially; exceeding 90% year-over-year company announces strategic digital rock characterization alliance with halliburton company announces q4 2023 quarterly dividend houston , nov. 1, 2023 /prnewswire/ -- core laboratories inc. (nyse: "clb") ("core", "core lab", or the "company") reported third quarter 2023 revenue of $125,300,000...
2023-10-09 08:45:00 - Press Release
Core Laboratories And Halliburton Announce Collaboration To Integrate Digital Rock Capabilities With Laboratory Measured Data
Houston , oct. 9, 2023 /prnewswire/ -- halliburton company (nyse: hal) and core laboratories inc. (nyse: clb) today announced a strategic collaboration in the u.s. to compress the delivery time of cutting-edge comprehensive digital rock data solutions from months to weeks, even while full petrophysical laboratory measurements are in progress. this collaboration combines core lab's industry-leading expertise in reservoir description and optimization technologies with halliburton's specialization in pore-scale digital rock analysis.
Latest News
2024-04-25 12:32:05 - Seeking Alpha
Core Laboratories Inc. (CLB) Q1 2024 Earnings Call Transcript
2024-04-25 12:01:19 - Zacks Investment Research
Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates
Core Laboratories' (CLB) second-quarter 2024 revenues are anticipated to be in the $130-$136 million range, while the operating income is estimated to be in the band of $14.5-$17.3 million.
2024-04-18 13:01:04 - Zacks Investment Research
What Makes Core Laboratories (CLB) a New Strong Buy Stock
Core Laboratories (CLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
2024-04-17 11:07:35 - Zacks Investment Research
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2024-03-29 10:46:47 - Zacks Investment Research
Why Core Laboratories (CLB) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
2024-02-01 11:16:06 - Zacks Investment Research
Core Laboratories (CLB) Q4 Earnings Miss Estimates, Sales In Line
Core Laboratories' (CLB) first-quarter 2024 revenues are anticipated in the $122-$128 million range, while the operating income is estimated in the band of $11.8-$14.3 million.
2024-01-31 20:01:08 - Zacks Investment Research
Here's What Key Metrics Tell Us About Core Laboratories (CLB) Q4 Earnings
While the top- and bottom-line numbers for Core Laboratories (CLB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
2024-01-31 19:46:05 - Zacks Investment Research
Core Laboratories (CLB) Q4 Earnings Miss Estimates
Core Laboratories (CLB) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.20 per share. This compares to earnings of $0.20 per share a year ago.
2024-01-10 13:17:03 - Seeking Alpha
U.S. Wide-Moat Stocks On Sale - The January 2024 Heat Map
2024-01-09 05:26:00 - InvestorPlace
February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio
In the investment space, uncovering stocks to sell with potential pitfalls is as crucial as identifying opportunities. This comprehensive review zooms in on the recent moves of three prominent companies that have sent ripples through the market.